GLP Watchdog

Hers vs Hims

Hers has an open FDA warning letter dated September 9, 2025. Hims has an open FDA warning letter dated September 9, 2025. No price lines up like for like. They share brand-name tirzepatide pen, but both price it at $299, and in each case that covers the medication only, with a separate membership on top.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hers / Hims

Hers logo

Hers

6.8/10

Hims logo

Hims

6.7/10

FDA warning letters
Pharmacy
Lowest standing price
$199/moCompounded semaglutide injection
$149/moBrand-name semaglutide pill, medication only, membership extra
States
All 50 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Hers
Visit Hims

Neither Hers nor Hims pays us. Links to them earn nothing. Scores: Hers 6.8, Hims 6.7. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Hims has an open FDA warning letter dated September 9, 2025.

  2. 02

    Hers names three pharmacies. Hims sells brand-name medication only.

  3. 03

    No price lines up like for like. They share brand-name tirzepatide pen, but both price it at $299, and in each case that covers the medication only, with a separate membership on top.

  4. 04

    Only Hers lists a price for compounded semaglutide injection. Only Hims lists a price for brand-name semaglutide pen, brand-name semaglutide pill and Foundayo (orforglipron) pill.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hers

Hims

Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

$299/mo

medication only, membership extra; not compared

Compounded semaglutide injection

$199/mo

$2,388 a year

Not sold or not priced
Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication
Medication
Billed separately
Clinician visits, coaching
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
Monthly membership, auto-renews
Refunds
No refund guaranteed once the pharmacy has processed an order
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Hers: September 28, 2026. Hims: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hers

6.8/10
  • Sells compounded semaglutide injection, which Hims does not price
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name semaglutide pill, which Hers does not price
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

Scores

Hers 6.8 · Hims 6.7 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.0A
vs
B
6.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

3.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Hers vs Hims: questions

Hers has an open FDA warning letter dated September 9, 2025. Hims has an open FDA warning letter dated September 9, 2025. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share brand-name tirzepatide pen, but both price it at $299, and in each case that covers the medication only, with a separate membership on top. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order. Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed.
Neither Hers nor Hims pays us. Links to them earn nothing. Scores: Hers 6.8, Hims 6.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks